BASF is the world’s leading chemical company. Its 113,000 employees, six Verbund sites and approximately 380 additional production sites support customers all over the globe.
BASF’s Pharma Ingredients & Services division has been a trusted partner to the pharmaceutical industry for decades. This means customers benefit from our unique expertise and extensive experience.
Innovation is at the heart of BASF’s business and our excipients and API portfolio reflect our commitment to research and development – as highlighted by products such as the efficient Kollicoat® coating range and our omega-3 portfolio.
We are known as an innovation leader in the solubilization area with an extensive range of solubilizers, co-solvents and matrices for all common dosage forms – including solids, liquids and semi-solids – featuring novel excipients particularly well suited for poorly soluble drugs. In addition, our numerous pharmaceutical ingredients for dermatological applications complete our broad range of excipients.
BASF has unparalleled expertise working with key technologies like the hot-melt extrusion (HME) process, offering products custom-made for this technology (i.e. Soluplus®). Beyond our leading-edge excipients portfolio customers have access to a broad range of first-class APIs, such as omega-3, caffeine, ibuprofen or pseudoephedrine and comprehensive custom synthesis services.